4//SEC Filing
van der Kamp Hilde Johanna 4
Accession 0000950170-25-003556
CIK 0001936258other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:58 PM ET
Size
7.3 KB
Accession
0000950170-25-003556
Insider Transaction Report
Form 4
van der Kamp Hilde Johanna
Director
Transactions
- Award
Ordinary Shares
2025-01-07+6,960→ 6,960 total - Award
Option (right to buy)
2025-01-06+32,500→ 32,500 totalExercise: $25.85Exp: 2035-01-06→ Ordinary Shares (32,500 underlying)
Footnotes (3)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
- [F2]Each RSU was granted on January 7, 2025 for no consideration.
- [F3]1/3 of the shares underlying the option will vest on January 6, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0002000565
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:58 PM ET
- Size
- 7.3 KB